Letter

(Not) warts and all

Government fully considered HPV vaccine

BMJ 2008; 337 doi: 10.1136/bmj.a2552 (Published 19 November 2008)
Cite this as: BMJ 2008;337:a2552

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. David M Salisbury, director of immunisation1
  1. 1Department of Health, London SW1A 2NS
  1. judith.moore{at}dh.gsi.gov.uk

    It was unfortunate that Hammond wrote his piece without asking us the government’s reasons for choosing the human papillomavirus (HPV) vaccine.1 We fully considered all of the issues he raised and much more that was scientific, logistic, and economic. …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular